Neoadjuvant Immune Checkpoint Inhibitor Combined With Chemotherapy in Non-small Cell Lung Cancer
Clinical trial NCT04945200 · UNKNOWN
Trial details
- NCT number
- NCT04945200
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-01-01
- Primary completion
- 2023-06-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.